Nidhi Saha

BDS Dentistry

I am a medical content writer and editor. My interests lie in public health awareness and medical communication. I have worked as a clinical dentist and as a consultant research writer in an Indian medical publishing house. It is my constant endeavor is to update knowledge on newer treatment modalities relating to various medical fields. I have also aided in proofreading and publication of manuscripts in accredited medical journals. I like to sketch, read and listen to music in my leisure time.

Articles from Nidhi

Survey assesses prevalence of H5N8 influenza in birds

The prevalence of the avian influenza H5N8 virus among birds and its pervasiveness based on geographical locations and time-point.

13 Nov 2022

Can monkeypox infection lead to myocarditis?

A recent study presents the first known case of myocarditis as a complication of monkeypox virus infection.

13 Nov 2022

Study links ultra-processed food consumption to premature death

The results of a new study depicted that ultra-processed food (UPF) consumption precipitated premature deaths in Brazil.

9 Nov 2022

Can prostaglandin E2 injection improve hair growth?

A new study demonstrated that prostaglandin E2 (PGE2) stimulates hair follicle growth.

9 Nov 2022

Updated CDC guidelines for prescribing opioids

The United States Centers CDC updated their clinical practice guidelines for opioid prescription in pain management.

8 Nov 2022

Poor sleep increases the risk of glaucoma

Snoring, daytime sleepiness, insomnia, and sleep duration may increase the risk of glaucoma.

8 Nov 2022

A review of vaccines against the respiratory syncytial virus

This study reviewed the epidemiology, molecular characteristics, populations affected by the virus, and vaccines against RSV.

3 Nov 2022

Vimentin is an important co-receptor for SARS-CoV-2 infection

Vimentin functions as a co-receptor for the entry of SARS-CoV-2 into host cells to facilitate infection.

2 Nov 2022

SpyCatcher-SpyTag technology used to develop recombinant protein-based intranasal vaccine against SARS-CoV-2

The findings of a new study showed that the intranasal SpyCage vaccine platform can be protective against SARS-CoV-2 and may prove to be a versatile and adaptable modality for the formulation of intranasal vaccines that target respiratory pathogens.

31 Oct 2022

Study refutes the nicotinic hypothesis of SARS-CoV-2 infection mechanism

A new study confirmed that the SARS-CoV-2 spike protein does not bind to human AChR’s orthosteric sites, nor does it compete with ACh, choline, or nicotine.

28 Oct 2022